Energy One (ASX: EOL) And STG Part Ways
The Energy One share price fell during the week after the board walked away from STG’s completely inadequate revised offer.
The Energy One share price fell during the week after the board walked away from STG’s completely inadequate revised offer.
3 ASX retail stocks reveal falling sales in their trading updates for Q1 FY 2024 but investors should keep an eye on one retailer.
Playside Studios (ASX: PLY) reports record quarterly revenue with growth from the higher margin Original IP division driving the growth.
Ansarada (ASX: AND) is a genuine software business, but the challenge is that demand is potentially quite cyclical.
Spacetalk (ASX: SPA) delivered strong revenue growth in Q1 FY 2024 but investors should pay closer attention to its financial health.
RPM Global (ASX: RUL) will institute investor presentations after their results, including allowing shareholders to ask questions.
Cettire (ASX: CTT) reported rapid growth in quarterly sales in Q1 FY 2024 but questions remain over scalability.
Dropsuite (ASX: DSE) reported record quarterly operating cashflow in Q3 FY 2024 and remains on a path to profitable growth.
Both RPM Global (ASX: RUL) and SRG Global (ASX: SRG) are reporting strong demand from their mining clients.
Xtek (ASX: XTE) released announcements during the week, including a plan to change its name to Highcom (ASX: HCL).
Austco Healthcare (ASX: AHC) shares are up around 50% in the last 6 months. But is the investment thesis on track?
Forager (ASX: FOR) has just announced longer term plans that would allow investors to exit much closer to net asset value…
Each of these companies have interesting prospects and saw their share price spike on FY 2023 results.
Here’s why the massive de-rate of the multiple on speculation about weight loss drugs reeks of panic.
Why did the Pro Medicus share price spike to a record of $78.85 this morning and what is the relevant news for Pro Medicus (ASX: PME)?
The EML Payments share price plunged in 2021 after the Central Bank of Ireland investigated it. So why is the EML share price up?
There are some tantalising aspects to the MedAdvisor (ASX: MDR) thesis, but is it a bit too risky?
Although the SRG Global (ASX: SRG) dividend was maintained, the second half earnings per share were a lot weaker than the first half.
The FY 2023 Laserbond results saw record earnings per share and a steady dividend, despite a lack of technology division sales.